ArticleACS infectious diseases2022

Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor.

Chunlong Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.